Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
Cancer biology & therapy
Saved in:
Main Authors: | Bhattacharya, B., Akram, M., Balasubramanian, I., Tam, K.K., Koh, K.X., Yee, M.Q., Soong, R. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116516 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in PIK3CA mutant gastric cancer cells
by: Bhattacharya, B., et al.
Published: (2014) -
KINASE-INDEPENDENT AND DEPENDENT MECHANISMS OF MAMMALIAN TARGET OF RAPAMYCIN IN MODULATING CELLULAR HOMEOSTASIS
by: TAN WEI QUAN BRYCE
Published: (2023) -
EFFECTS OF INHIBITING THE MAMMALIAN TARGET OF RAPAMYCIN (MTOR) PATHWAY AND TELOMERASE IN BREAST CANCER CELLS
by: GOPALAKRISHNAN KALPANA
Published: (2011) -
Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
by: Bhattacharya B., et al.
Published: (2020) -
TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER
by: DANIEL TAN SHAO WENG
Published: (2017)